Concepedia

Publication | Closed Access

Corticosteroids during pregnancy and oral clefts: A case-control study

283

Citations

11

References

1998

Year

TLDR

The effect of systemic corticosteroid use in the first trimester on congenital malformations remains unresolved. This case‑control study examines the association between first‑trimester corticosteroid exposure and oral clefts in newborns. Data come from the Spanish Collaborative Study of Congenital Malformations, including 1,184 liveborn infants with nonsyndromic oral clefts. Logistic regression shows first‑trimester corticosteroid exposure increases the risk of cleft lip (OR = 6.55, 95 % CI 1.44–29.76, P = 0.015) after adjusting for confounders. Published in Teratology 58:2–5 (1998); © 1998 Wiley‑Liss, Inc.

Abstract

The question of whether systemic use of corticosteroids during the first trimester of pregnancy increases the risk of congenital malformations in people has still not been resolved. Here, we present the results of a case-control study on the relationship of corticosteroids during pregnancy and oral clefts in the newborn infant. Data are derived from the Spanish Collaborative Study of Congenital Malformations (ECEMC). Case subjects were 1,184 liveborn infants with nonsyndromic oral clefts. The results of the logistic regression analysis, show a relationship between exposure to corticosteroids during the first trimester of pregnancy and an increased risk of cleft lip (with or without cleft palate) in the newborn infants (OR = 6.55; CI = 1.44–29.76; P = 0.015), controlled for potential confounder factors, such as maternal smoking, maternal hyperthermia, first-degree malformed relatives with cleft lip with or without cleft palate, and maternal treatment with antiepileptics, benzodiazepines, metronidazole, or sex hormones during the first trimester of pregnancy. Thus, we believe that the use of corticosteroids during the first trimester of pregnancy, should be restricted to the following situations: for life-threatening situations, for those diseases without any other safe therapeutic alternative, or for those cases with replacement therapy. Teratology 58:2–5, 1998. © 1998 Wiley-Liss, Inc.

References

YearCitations

Page 1